Assessment of rituximab-abbs, a biosimilar, and rituximab outcomes in patients with CLL or NHL: A real-world UK study

Authors: McBride, Ali ^*, Daniel, Shoshana, Driessen, Maurice T., Szende, Agota, Choudhry, Azhar, Tian, Marc, Ariely, Rinat, Thompson, Stephen

Source: In Leukemia Research December 2021 111

Safety evaluation of adenovirus type 4 and type 7 vaccine live, oral in military recruits

Authors: Choudhry, Azhar, Mathena, Julie, Albano, Jessica D., Yacovone, Margaret, Collins, Limone

Source: In Vaccine 31 August 2016 34(38):4558-4564

Real-world healthcare resource utilization and costs in patients with chronic lymphocytic leukemia: differences between patients treated with first-line ibrutinib or bendamustine + rituximab.

Authors: Irwin, Debra, Wilson, Kathleen, Thompson, Stephen, Choudhry, Azhar

Source: Current Medical Research & Opinion; Apr2021, Vol. 37 Issue 4, p623-628, 6p

Subject Terms: RITUXIMAB, CHRONIC lymphocytic leukemia, MEDICAL prescriptions, MEDICAL care costs

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Efficacy of rasagiline in PD patients with mild cognitive impairment

Authors: Weintraub, Daniel, Hauser, Robert A., Davis, Matthew, Choudhry, Azhar

Source: In Parkinsonism and Related Disorders January 2016 22 Supplement 2:e91-e91

INTER-RATER RELIABILITY AND ERROR ANALYSIS OF THE SCALES FOR OUTCOMES OF PARKINSON’S DISEASE: COGNITION (SCOPA-COG) IN MODERATO–A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY TO ASSESS THE EFFECT OF RASAGILINE ON MILD COGNITIVE IMPAIRMENT IN PD

Authors: Hilsabeck, Robin C., Nations, Kari R., Tanenbaum, Russell, Grubb, Beth, Choudhry, Azhar

Source: In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2014 10(4) Supplement:P854-P854

This result is not displayed to guests.
Login for full access.